PathoQuest, Charles River Laboratories Partner

News   Sep 30, 2016

 
PathoQuest, Charles River Laboratories Partner
 

RELATED ARTICLES

CRISPR Reveals the Sugary Secrets of the Cancer-related Notch Protein

News

New research shows that the fucose and glucose modifications serve as quality-control markers that allow Notch to be transported to its final destination in the cell membrane.

READ MORE

Superior Pathological Diagnosis Using Transparent Tissues

News

In a new study researchers report CUBIC, a technique including a tissue processing that makes human organs transparent, and provides better assessment of lesions for pathological diagnosis.

READ MORE

Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay

News

Agilent Technologies has obtained 510(k) clearance from the FDA for the GenetiSure Dx Postnatal Assay: its first comparative genomic hybridization (CGH) assay for diagnostic use.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE